By Matthew Bultman ( July 12, 2017, 6:20 PM EDT) -- The U.K. Supreme Court explained Wednesday why it ruled in favor of Eli Lilly and Co. in a patent dispute with Actavis UK Ltd. over Lilly's top-selling cancer drug, Alimta, in a decision that reformulates the test for patent infringement in Britain....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.